Friday, July 10, 2026

Drug profile · INN

nelfinavir

nelfinavir (VIRACEPT) is an FDA-listed pharmaceutical active ingredient.

EMA: withdrawn Antiinfectives for systemic use (J05) J05AE04
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — nelfinavir
Class
Antiinfectives for systemic use (J05)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

nelfinavir (VIRACEPT) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN nelfinavir
Brand VIRACEPT
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AE04

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. Nelfinavir and Omeprazole Approved · Jasper Therapeutics · Healthy Volunteers

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is nelfinavir?

nelfinavir (VIRACEPT) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for nelfinavir?

VIRACEPT is a marketed brand name for nelfinavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.